Technology Innovation Will Help Prepare Drug Discovery For Smart Screening Era

logo-astrazeneca

In a recent paper, Dr Clive Green and Dr Philip Spencer, both of AstraZeneca (a Titian customer), discuss how drug discovery is undergoing a transformation powered by advances that provide more knowledge from biological assays, allow for screening orders of magnitude more molecules and enable smarter selection of compounds.

To read the full paper, click here

Tags: Customer: AstraZenica